Zdrowie i gospodarka · 23/09/2020
FDA Clears PREXXARTAN (Valsartan) Oral Solution for Sale
The FDA has determined that PREXXARTAN (valsartan) oral solution, 20 mg/5 mL and 80 mg/20 mL, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →